Breakout Ventures
VC · San Francisco · United States
Stages
Investment region
Industries
Profile
Breakout Ventures is a venture capital firm based in San Francisco, California, founded in 2016. The firm is led by a team of scientists and operators with deep technical expertise and commercial fluency, focusing on scaling scientific innovation. They are known for their rigorous partnership approach and their ability to recognize market inflection points early. The firm invests in early-stage companies operating in sectors such as biotechnology, healthcare, sustainability, and materials. They typically invest in Seed and Series A rounds, with check sizes ranging from $500K to $6M. Breakout Ventures manages several funds, including Breakout Ventures Fund II with $113M AUM launched in 2021, and Fund III with $114M AUM launched recently. Notable investments by Breakout Ventures include CytoVale - diagnosing immune-mediated diseases, Modern Meadow - sustainable biofabrication, STRM.BIO - in vivo gene therapy, Ecovative Design - mycelium-grown materials, and Twelve - transforming carbon dioxide emissions into useful chemicals.
Contacts (2)
| Name | Title | Phone | ||
|---|---|---|---|---|
| Partner | — | — | — | |
| Managing Partner | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.